Risk profiling of patients (pts) with previously untreated Diffuse Large B-Cell Lymphoma (DLBCL) by measuring circulating tumor DNA (ctDNA): 3-year update of the POLARIX study

被引：0
|
作者：
Oellerich, T. [1 ]
Lenz, G. [2 ]
Herrera, A. F. [3 ]
McCord, R. [4 ]
Kimes, P. [4 ]
Jardin, F. [5 ,6 ]
Trneny, M. [7 ]
Flowers, C. R. [8 ]
Sehn, L. H. [9 ,10 ]
Salles, G. [11 ]
Sharman, J. P. [12 ]
Tilly, H. [5 ,6 ]
Friedberg, J. W. [13 ]
Herbaux, C. [14 ]
Matasar, M. [15 ]
Haioun, C. [16 ]
Tracy, S. [4 ]
Hirata, J. [4 ]
Lee, C. [4 ]
Jiang, Y. [4 ]
Morschhauser, F. [17 ]
机构：
[1] Univ Clin Frankfurt, Dept Haematol Oncol, Frankfurt, Germany
[2] Univ Hosp Munster, Munster, Germany
[3] City Hope Natl Med Ctr, Duarte, CA USA
[4] Genentech Inc, San Francisco, CA USA
[5] Ctr Henri Becquerel, Rouen, France
[6] Univ Rouen, Rouen, France
[7] Charles Univ Gen Hosp, Prague, Czech Republic
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[9] BC Canc Ctr Lymphoid Canc, Vancouver, BC, Canada
[10] Univ British Columbia, Vancouver, BC, Canada
[11] Mem Sloan Kettering Canc Ctr, New York, NY USA
[12] Willamette Valley Canc Inst & Res Ctr, Florence, SC USA
[13] Univ Rochester, Rochester, NY USA
[14] Univ Montpellier, Montpellier, France
[15] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[16] Grp Hosp Henri Mondor Chenevier, Creteil, France
[17] Univ Lille, Ctr Hosp Univ, Lille, France
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V105
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [1] Risk Profiling of Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) By Measuring Circulating Tumor DNA (ctDNA): Results from the POLARIX Study
    Herrera, Alex F.
    McCord, Ronald
    Kimes, Patrick
    Jardin, Fabrice
    Lenz, Georg
    Trneny, Marek
    Flowers, Christopher R.
    Sehn, Laurie H.
    Salles, Gilles
    Sharman, Jeff P.
    Tilly, Herve
    Friedberg, Jonathan W.
    Herbaux, Charles
    Matasar, Matthew J.
    Haioun, Corinne
    Tracy, Samuel
    Hirata, Jamie
    Lee, Calvin
    Jiang, Yanwen
    Morschhauser, Franck
    BLOOD, 2022, 140 : 1297 - 1300
  • [2] Circulating tumor DNA (ctDNA) status and clinical outcomes in patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) in the POLARIX study.
    Herrera, Alex Francisco
    Tracy, Samuel
    Sehn, Laurie Helen
    Jardin, Fabrice
    Lenz, Georg
    Trneny, Marek
    Salles, Gilles A.
    Flowers, Christopher
    Tilly, Herve
    Sharman, Jeff Porter
    Friedberg, Jonathan W.
    Balasubramanian, Sandhya
    Raghavan, Vibha
    Hirata, Jamie H.
    Lee, Calvin
    Jiang, Yanwen
    Morschhauser, Franck
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA
    Herrera, Alex F.
    Tracy, Samuel
    Croft, Brandon
    Opat, Stephen
    Ray, Jill
    Lovejoy, Alex F.
    Musick, Lisa
    Paulson, Joseph N.
    Sehn, Laurie H.
    Jiang, Yanwen
    BLOOD ADVANCES, 2022, 6 (06) : 1651 - 1660
  • [4] Risk Profiling of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients By Measuring Circulating Tumor DNA
    Herrera, Alex F.
    Tracy, Samuel
    Croft, Brandon
    Opat, Stephen
    Ray, Jill
    Musick, Lisa
    Paulson, Joseph N.
    Sehn, Laurie H.
    Jiang, Yanwen
    BLOOD, 2020, 136
  • [5] Subgroup analysis of elderly patients (pts) with diffuse large B-cell lymphoma (DLBCL) in the phase 3 POLARIX study.
    Hu, Bei
    Reagan, Patrick Michael
    Sehn, Laurie Helen
    Sharman, Jeff Porter
    Hertzberg, Mark
    Zhang, Huilai
    Kim, Austin Injae
    Herbaux, Charles
    Molina, Lysiane
    Maruyama, Dai
    Smolewski, Piotr
    Stenner, Frank
    Craine, Veronica
    Kothari, Rucha
    Hirata, Jamie H.
    Sahin, Deniz
    Sugidono, Matthew Dean Sei
    Lee, Calvin
    Tilly, Herve
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Comparison of statistical methods for extrapolating survival in previously untreated diffuse large B-cell lymphoma: results based on the POLARIX study
    Ho, Rodrigo S.
    Launonen, Aino
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1178 - 1189
  • [7] A Proposed Prognostic Score Including Circulating Free DNA (ctDNA) Concentration in Diffuse Large B-Cell Lymphoma (DLBCL): Single Centre Study
    Jamal, Esraa
    Elbogdady, Mohamed
    Saleh, Layla
    Shamaah, Sameh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S454 - S455
  • [8] Clonal Ig DNA Detection In Plasma From Patients with Untreated Diffuse Large B-Cell Lymphoma (DLBCL)
    Wagner-Johnston, Nina
    Bartlett, Nancy L.
    Payton, Jacqueline E.
    Trinkaus, Kathryn
    Sharma, Akash
    Timm, Justina
    Ambinder, Richard F.
    BLOOD, 2010, 116 (21) : 1288 - 1288
  • [9] Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
    Roschewski, Mark
    Dunleavy, Kieron
    Pittaluga, Stefania
    Moorhead, Martin
    Pepin, Francois
    Kong, Katherine
    Shovlin, Margaret
    Jaffe, Elaine S.
    Staudt, Louis M.
    Lai, Catherine
    Steinberg, Seth M.
    Chen, Clara C.
    Zheng, Jianbiao
    Willis, Thomas D.
    Faham, Malek
    Wilson, Wyndham H.
    LANCET ONCOLOGY, 2015, 16 (05): : 541 - 549
  • [10] RCHOPB: Feasibility study of RCHOP plus bevacizumab (B) in patients (pts) with diffuse large B-cell lymphoma (DLBCL)
    Hawkes, E. A.
    Chau, I.
    Thomas, K.
    Oates, J. R.
    Webb, J.
    Costello, C.
    Johnson, P. W.
    Cunningham, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345